Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia
Authors:
- U. Vivian UkahUUU. Vivian Ukah
- Beth PayneBPBeth Payne
- Jennifer A. HutcheonJHJennifer A. Hutcheon
- J. Mark AnserminoJAJ. Mark Ansermino
- Wessel GanzevoortWGWessel Ganzevoort
- Shakila ThangaratinamSTShakila Thangaratinam
- Laura A. MageeLMLaura A. Magee
- Peter von DadelszenPDPeter von Dadelszen
Open Access
- 1 April 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 71 (4) , 659-665
Abstract
Early-onset preeclampsia is associated with severe maternal and perinatal complications. The fullPIERS model (Preeclampsia Integrated Estimate of Risk) showed both internal and external validities for predicting adverse maternal outcomes within 48 hours for women admitted with preeclampsia at any gestational age. This ability to recognize women at the highest risk of complications earlier could aid in preventing these adverse outcomes through improved management. Because the majority (≈70%) of the women in the model development had late-onset preeclampsia, we assessed the performance of the fullPIERS model in women with early-onset preeclampsia to determine whether it will be useful in this subgroup of women with preeclampsia. Three cohorts of women admitted with early-onset preeclampsia between 2012 and 2016, from tertiary hospitals in Canada, the Netherlands, and United Kingdom, were used. Using the published model equation, the probability of experiencing an adverse maternal outcome was calculated for each woman, and model performance was evaluated based on discrimination, calibration, and stratification. The total data set included 1388 women, with an adverse maternal outcome rate of 7.3% within 48 hours of admission. The model had good discrimination, with an area under the receiver operating characteristic curve of 0.80 (95% confidence interval, 0.75–0.86), and a calibration slope of 0.68. The estimated likelihood ratio at the predicted probability of ≥30% was 23.4 (95% confidence interval, 14.83–36.79), suggesting a strong evidence to rule in adverse maternal outcomes. The fullPIERS model will aid in identifying women admitted with early-onset preeclampsia in similar settings who are at the highest risk of adverse outcomes, thereby allowing timely and effective interventions.Keywords
This publication has 23 references indexed in Scilit:
- Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS modelThe Lancet, 2011
- External Validity of Risk Models: Use of Benchmark Values to Disentangle a Case-Mix Effect From Incorrect CoefficientsAmerican Journal of Epidemiology, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating by Ewout W. SteyerbergInternational Statistical Review, 2009
- Predicting Adverse Outcomes in Women with Severe Pre-eclampsiaSeminars in Perinatology, 2009
- Expectant Management of Severe Preeclampsia Remote from Term: A Structured Systematic ReviewHypertension in Pregnancy, 2009
- Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology, 2006
- Substantial effective sample sizes were required for external validation studies of predictive logistic regression modelsJournal of Clinical Epidemiology, 2005
- Diagnostic tests 4: likelihood ratiosBMJ, 2004